What is Lemaitre Vasculr's earnings per share (EPS)?

Lemaitre Vasculr (LMAT) reported diluted earnings per share of $2.52 for fiscal year 2025. This represents a 30.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Lemaitre Vasculr Financials

LMAT

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Lemaitre Vasculr (LMAT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 79/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Lemaitre Vasculr has an operating margin of 27.2%, meaning the company retains $27 of operating profit per $100 of revenue. This strong profitability earns a score of 83/100, reflecting efficient cost management and pricing power. This is up from 23.8% the prior year.

Growth

Lemaitre Vasculr's revenue grew 13.5% year-over-year to $249.6M, a solid pace of expansion. This earns a growth score of 56/100.

Leverage

Lemaitre Vasculr carries a low D/E ratio of 0.56, meaning only $0.56 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 91/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 12.89, Lemaitre Vasculr holds $12.89 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

100

Lemaitre Vasculr converts 29.8% of revenue into free cash flow ($74.5M). This strong cash generation earns a score of 100/100.

Returns

Lemaitre Vasculr's ROE of 14.7% shows moderate profitability relative to equity, earning a score of 44/100. This is up from 13.1% the prior year.

Altman Z-Score Safe

8.70

Lemaitre Vasculr scores 8.70, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.5B) relative to total liabilities ($222.2M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

6/9

Lemaitre Vasculr passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.41x

For every $1 of reported earnings, Lemaitre Vasculr generates $1.41 in operating cash flow ($81.3M OCF vs $57.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

13.1x

Lemaitre Vasculr earns $13.1 in operating income for every $1 of interest expense ($67.9M vs $5.2M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$249.6M

YoY+13.5%

5Y CAGR+14.0%

10Y CAGR+12.3%

Lemaitre Vasculr generated $249.6M in revenue in fiscal year 2025. This represents an increase of 13.5% from the prior year.

EBITDA

$78.3M

YoY+26.6%

5Y CAGR+16.1%

10Y CAGR+18.0%

Lemaitre Vasculr's EBITDA was $78.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 26.6% from the prior year.

Net Income

$57.7M

YoY+31.1%

5Y CAGR+22.2%

10Y CAGR+22.2%

Lemaitre Vasculr reported $57.7M in net income in fiscal year 2025. This represents an increase of 31.1% from the prior year.

EPS (Diluted)

$2.52

YoY+30.6%

5Y CAGR+19.4%

10Y CAGR+19.6%

Lemaitre Vasculr earned $2.52 per diluted share (EPS) in fiscal year 2025. This represents an increase of 30.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$74.5M

YoY+100.4%

5Y CAGR+18.5%

10Y CAGR+23.3%

Lemaitre Vasculr generated $74.5M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 100.4% from the prior year.

Cash & Debt

$28.2M

YoY+10.3%

5Y CAGR+1.1%

10Y CAGR+0.3%

Lemaitre Vasculr held $28.2M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.80

YoY+25.0%

5Y CAGR+16.1%

10Y CAGR+17.5%

Lemaitre Vasculr paid $0.80 per share in dividends in fiscal year 2025. This represents an increase of 25.0% from the prior year.

Shares Outstanding

23M

YoY+1.0%

Lemaitre Vasculr had 23M shares outstanding in fiscal year 2025. This represents an increase of 1.0% from the prior year.

Margins & Returns

Gross Margin

71.5%

YoY+2.9pp

5Y CAGR+6.1pp

10Y CAGR+2.4pp

Lemaitre Vasculr's gross margin was 71.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.9 percentage points from the prior year.

Operating Margin

27.2%

YoY+3.4pp

5Y CAGR+5.0pp

10Y CAGR+12.5pp

Lemaitre Vasculr's operating margin was 27.2% in fiscal year 2025, reflecting core business profitability. This is up 3.4 percentage points from the prior year.

Net Margin

23.1%

YoY+3.1pp

5Y CAGR+6.7pp

10Y CAGR+13.2pp

Lemaitre Vasculr's net profit margin was 23.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 3.1 percentage points from the prior year.

Return on Equity

14.7%

YoY+1.6pp

5Y CAGR+2.4pp

10Y CAGR+4.7pp

Lemaitre Vasculr's ROE was 14.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.6 percentage points from the prior year.

Capital Allocation

R&D Spending

$14.1M

YoY-9.7%

5Y CAGR+7.0%

10Y CAGR+9.9%

Lemaitre Vasculr invested $14.1M in research and development in fiscal year 2025. This represents a decrease of 9.7% from the prior year.

Share Buybacks

$1.8M

YoY+5.9%

5Y CAGR+26.1%

10Y CAGR+21.2%

Lemaitre Vasculr spent $1.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 5.9% from the prior year.

Capital Expenditures

$6.8M

YoY-2.6%

5Y CAGR+17.9%

10Y CAGR+11.6%

Lemaitre Vasculr invested $6.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 2.6% from the prior year.

LMAT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$249.6M+13.5%	$219.9M+13.6%	$193.5M+19.7%	$161.7M+4.7%	$154.4M+19.4%	$129.4M
Cost of Revenue	$71.1M+3.0%	$69.0M+3.8%	$66.4M+17.1%	$56.8M+7.0%	$53.0M+18.5%	$44.7M
Gross Profit	$178.5M+18.3%	$150.9M+18.8%	$127.0M+21.1%	$104.9M+3.5%	$101.4M+19.8%	$84.6M
R&D Expenses	$14.1M-9.7%	$15.7M-7.8%	$17.0M+27.6%	$13.3M+12.7%	$11.8M+16.9%	$10.1M
SG&A Expenses	$42.0M+15.9%	$36.3M+13.9%	$31.8M+10.7%	$28.7M+12.7%	$25.5M+13.3%	$22.5M
Operating Income	$67.9M+30.0%	$52.3M+42.3%	$36.7M+36.8%	$26.8M-26.3%	$36.4M+26.5%	$28.8M
Interest Expense	$5.2M+2428.8%	$205K	$0	$0-100.0%	$2.2M+69.4%	$1.3M
Income Tax	$17.4M+35.9%	$12.8M+37.0%	$9.4M+36.7%	$6.9M-7.1%	$7.4M+20.3%	$6.1M
Net Income	$57.7M+31.1%	$44.0M+46.3%	$30.1M+45.9%	$20.6M-23.3%	$26.9M+26.8%	$21.2M
EPS (Diluted)	$2.52+30.6%	$1.93+44.0%	$1.34+44.1%	$0.93-25.6%	$1.25+20.2%	$1.04

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$64.5M+5.6%	$61.0M-5.0%	$64.2M+7.3%	$59.9M+7.5%	$55.7M+1.6%	$54.8M-1.8%	$55.8M+4.4%	$53.5M
Cost of Revenue	$18.3M+21.0%	$15.1M-21.6%	$19.3M+4.4%	$18.5M+7.7%	$17.1M-2.9%	$17.6M+1.5%	$17.4M+3.4%	$16.8M
Gross Profit	$46.2M+0.5%	$46.0M+2.2%	$45.0M+8.6%	$41.4M+7.3%	$38.6M+3.8%	$37.2M-3.4%	$38.5M+4.9%	$36.7M
R&D Expenses	$3.5M+19.0%	$3.0M-16.1%	$3.5M-13.5%	$4.1M+13.2%	$3.6M-1.0%	$3.7M-14.7%	$4.3M+4.7%	$4.1M
SG&A Expenses	$10.4M-3.3%	$10.8M+3.4%	$10.4M-0.9%	$10.5M+10.5%	$9.5M+6.3%	$8.9M+1.3%	$8.8M-2.1%	$9.0M
Operating Income	$18.8M-7.3%	$20.3M+25.8%	$16.1M+27.8%	$12.6M-1.8%	$12.9M-2.2%	$13.1M-8.6%	$14.4M+21.1%	$11.9M
Interest Expense	$1.3M+0.1%	$1.3M-0.2%	$1.3M+0.7%	$1.3M+529.3%	$205K	$0	$0	$0
Income Tax	$4.7M-9.5%	$5.2M+21.4%	$4.3M+32.8%	$3.2M+13.9%	$2.8M-16.8%	$3.4M-7.3%	$3.7M+26.5%	$2.9M
Net Income	$15.6M-10.3%	$17.4M+26.0%	$13.8M+25.1%	$11.0M-1.5%	$11.2M+0.4%	$11.1M-5.8%	$11.8M+19.6%	$9.9M
EPS (Diluted)	N/A	$0.75+25.0%	$0.60+25.0%	$0.48	N/A	$0.49-5.8%	$0.52+18.2%	$0.44

LMAT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$615.7M+11.6%	$551.8M+59.1%	$346.8M+11.7%	$310.5M+6.0%	$292.8M+15.8%	$252.8M
Current Assets	$468.2M+16.4%	$402.2M+106.7%	$194.6M+20.3%	$161.7M+15.6%	$139.9M+48.4%	$94.3M
Cash & Equivalents	$28.2M+10.3%	$25.6M+5.5%	$24.3M+26.8%	$19.1M+38.1%	$13.9M-48.2%	$26.8M
Inventory	$34.4M-0.7%	$34.7M+11.4%	$31.1M+16.6%	$26.7M+5.5%	$25.3M-10.1%	$28.1M
Accounts Receivable	$33.6M+11.8%	$30.1M+19.9%	$25.1M+13.7%	$22.0M+12.3%	$19.6M+0.4%	$19.6M
Goodwill	$65.9M0.0%	$65.9M0.0%	$65.9M0.0%	$65.9M0.0%	$65.9M0.0%	$65.9M
Total Liabilities	$222.2M+3.6%	$214.5M+338.9%	$48.9M+15.6%	$42.3M+9.4%	$38.7M-51.8%	$80.2M
Current Liabilities	$36.3M+18.7%	$30.6M+2.4%	$29.9M+18.0%	$25.3M+16.1%	$21.8M-13.3%	$25.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$393.5M+16.7%	$337.3M+13.2%	$297.9M+11.1%	$268.2M+5.5%	$254.2M+47.3%	$172.6M
Retained Earnings	$184.7M+27.3%	$145.1M+25.7%	$115.4M+18.1%	$97.8M+10.9%	$88.1M+24.9%	$70.6M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$615.7M+2.9%	$598.1M+3.5%	$577.6M+3.9%	$556.0M+0.8%	$551.8M+46.4%	$377.0M+3.8%	$363.1M+2.6%	$354.0M
Current Assets	$468.2M+3.6%	$452.0M+5.1%	$430.1M+5.4%	$408.1M+1.5%	$402.2M+77.1%	$227.1M+6.7%	$212.8M+4.9%	$203.0M
Cash & Equivalents	$28.2M+10.8%	$25.5M-6.2%	$27.2M+7.2%	$25.3M-1.1%	$25.6M+21.9%	$21.0M-5.7%	$22.3M-16.3%	$26.6M
Inventory	$34.4M-5.1%	$36.3M+8.3%	$33.5M-1.3%	$33.9M-2.2%	$34.7M+2.6%	$33.8M-2.1%	$34.5M+10.8%	$31.1M
Accounts Receivable	$33.6M+3.7%	$32.4M-11.3%	$36.5M+4.1%	$35.1M+16.8%	$30.1M-6.8%	$32.3M+4.7%	$30.8M+1.9%	$30.2M
Goodwill	$65.9M0.0%	$65.9M0.0%	$65.9M0.0%	$65.9M0.0%	$65.9M0.0%	$65.9M0.0%	$65.9M0.0%	$65.9M
Total Liabilities	$222.2M+1.4%	$219.1M+2.0%	$214.9M+3.1%	$208.4M-2.8%	$214.5M+366.9%	$46.0M+5.5%	$43.5M-4.2%	$45.5M
Current Liabilities	$36.3M+9.1%	$33.3M+8.0%	$30.8M+24.5%	$24.7M-19.2%	$30.6M+4.3%	$29.3M+15.3%	$25.4M-5.1%	$26.8M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$393.5M+3.9%	$378.9M+4.5%	$362.7M+4.3%	$347.6M+3.0%	$337.3M+1.9%	$331.1M+3.6%	$319.5M+3.6%	$308.5M
Retained Earnings	$184.7M+6.4%	$173.7M+8.0%	$160.8M+6.1%	$151.6M+4.5%	$145.1M+5.5%	$137.5M+5.8%	$130.0M+6.8%	$121.7M

LMAT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$81.3M+84.1%	$44.1M+20.1%	$36.8M+44.8%	$25.4M-27.7%	$35.1M+0.9%	$34.8M
Capital Expenditures	$6.8M-2.6%	$7.0M-4.2%	$7.3M+125.0%	$3.2M-33.9%	$4.9M+63.7%	$3.0M
Free Cash Flow	$74.5M+100.4%	$37.2M+26.0%	$29.5M+33.1%	$22.1M-26.7%	$30.2M-5.0%	$31.8M
Investing Cash Flow	-$64.9M+67.5%	-$200.1M-709.7%	-$24.7M-138.3%	-$10.4M+83.0%	-$61.1M-15.5%	-$52.9M
Financing Cash Flow	-$14.5M-109.2%	$158.1M+2317.1%	-$7.1M+22.8%	-$9.2M-167.4%	$13.7M-57.4%	$32.2M
Dividends Paid	$18.1M+25.9%	$14.4M+15.5%	$12.4M+13.3%	$11.0M+17.7%	$9.3M+21.3%	$7.7M
Share Buybacks	$1.8M+5.9%	$1.7M+101.5%	$853K+32.9%	$642K-20.0%	$802K+40.7%	$570K

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$23.2M-19.5%	$28.8M+41.8%	$20.3M+124.5%	$9.0M-40.5%	$15.2M+6.6%	$14.2M+48.0%	$9.6M+89.8%	$5.1M
Capital Expenditures	$1.8M-22.1%	$2.3M+70.0%	$1.3M-3.0%	$1.4M-32.3%	$2.0M+22.4%	$1.7M-11.1%	$1.9M+37.1%	$1.4M
Free Cash Flow	$21.4M-19.3%	$26.5M+39.8%	$18.9M+147.5%	$7.7M-41.7%	$13.1M+4.5%	$12.6M+62.3%	$7.7M+109.3%	$3.7M
Investing Cash Flow	-$16.8M+38.7%	-$27.4M-67.9%	-$16.3M-278.4%	-$4.3M+97.5%	-$173.9M-1251.8%	-$12.9M-16.9%	-$11.0M-366.0%	-$2.4M
Financing Cash Flow	-$3.6M-21.6%	-$3.0M-6.7%	-$2.8M+47.2%	-$5.2M-103.2%	$164.1M+5312.2%	-$3.1M-9.7%	-$2.9M-7459.0%	$39K
Dividends Paid	$4.5M0.0%	$4.5M+0.3%	$4.5M+0.1%	$4.5M+25.5%	$3.6M+0.1%	$3.6M+0.1%	$3.6M+0.1%	$3.6M
Share Buybacks	$1.2M	$0-100.0%	$4K-99.3%	$601K-55.6%	$1.4M+135200.0%	$1K-85.7%	$7K-98.0%	$358K

LMAT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	71.5%+2.9pp	68.6%+3.0pp	65.7%+0.8pp	64.9%-0.8pp	65.6%+0.2pp	65.4%
Operating Margin	27.2%+3.4pp	23.8%+4.8pp	19.0%+2.4pp	16.6%-7.0pp	23.6%+1.3pp	22.3%
Net Margin	23.1%+3.1pp	20.0%+4.5pp	15.6%+2.8pp	12.8%-4.6pp	17.4%+1.0pp	16.4%
Return on Equity	14.7%+1.6pp	13.1%+2.9pp	10.1%+2.4pp	7.7%-2.9pp	10.6%-1.7pp	12.3%
Return on Assets	9.4%+1.4pp	8.0%-0.7pp	8.7%+2.0pp	6.7%-2.5pp	9.2%+0.8pp	8.4%
Current Ratio	12.89-0.2	13.14+6.6	6.51+0.1	6.39-0.0	6.41+2.7	3.75
Debt-to-Equity	0.56-0.1	0.64+0.5	0.160.0	0.160.0	0.15-0.3	0.47
FCF Margin	29.8%+12.9pp	16.9%+1.7pp	15.2%+1.5pp	13.7%-5.9pp	19.6%-5.0pp	24.6%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	71.7%-3.6pp	75.3%+5.3pp	70.0%+0.8pp	69.2%-0.1pp	69.3%+1.4pp	67.8%-1.1pp	68.9%+0.3pp	68.6%
Operating Margin	29.2%-4.0pp	33.3%+8.1pp	25.1%+4.0pp	21.1%-2.0pp	23.1%-0.9pp	24.0%-1.8pp	25.8%+3.6pp	22.2%
Net Margin	24.2%-4.3pp	28.4%+7.0pp	21.4%+3.1pp	18.4%-1.7pp	20.1%-0.3pp	20.3%-0.9pp	21.2%+2.7pp	18.5%
Return on Equity	4.0%-0.6pp	4.6%+0.8pp	3.8%+0.6pp	3.2%-0.2pp	3.3%-0.1pp	3.4%-0.3pp	3.7%+0.5pp	3.2%
Return on Assets	2.5%-0.4pp	2.9%+0.5pp	2.4%+0.4pp	2.0%-0.0pp	2.0%-0.9pp	2.9%-0.3pp	3.3%+0.5pp	2.8%
Current Ratio	12.89-0.7	13.58-0.4	13.96-2.5	16.49+3.4	13.14+5.4	7.74-0.6	8.36+0.8	7.57
Debt-to-Equity	0.56-0.0	0.58-0.0	0.590.0	0.60-0.0	0.64+0.5	0.140.0	0.14-0.0	0.15
FCF Margin	33.2%-10.2pp	43.4%+13.9pp	29.5%+16.7pp	12.8%-10.8pp	23.6%+0.6pp	22.9%+9.1pp	13.9%+6.9pp	6.9%

Similar Companies

Dentsply Sirona Inc XRAY

$2.3B

Icu Medical ICUI

$3.0B

Envista Holdings Corp NVST

$4.2B

Teleflex Inc TFX

$5.2B

Bausch + Lomb Corporation BLCO

$5.8B

Frequently Asked Questions

What is Lemaitre Vasculr's annual revenue?

Lemaitre Vasculr (LMAT) reported $249.6M in total revenue for fiscal year 2025. This represents a 13.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Lemaitre Vasculr's revenue growing?

Lemaitre Vasculr (LMAT) revenue grew by 13.5% year-over-year, from $219.9M to $249.6M in fiscal year 2025.

Is Lemaitre Vasculr profitable?

Yes, Lemaitre Vasculr (LMAT) reported a net income of $57.7M in fiscal year 2025, with a net profit margin of 23.1%.

What is Lemaitre Vasculr's EBITDA?

Lemaitre Vasculr (LMAT) had EBITDA of $78.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Lemaitre Vasculr's gross margin?

Lemaitre Vasculr (LMAT) had a gross margin of 71.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Lemaitre Vasculr's operating margin?

Lemaitre Vasculr (LMAT) had an operating margin of 27.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Lemaitre Vasculr's net profit margin?

Lemaitre Vasculr (LMAT) had a net profit margin of 23.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Lemaitre Vasculr pay dividends?

Yes, Lemaitre Vasculr (LMAT) paid $0.80 per share in dividends during fiscal year 2025.

What is Lemaitre Vasculr's return on equity (ROE)?

Lemaitre Vasculr (LMAT) has a return on equity of 14.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Lemaitre Vasculr's free cash flow?

Lemaitre Vasculr (LMAT) generated $74.5M in free cash flow during fiscal year 2025. This represents a 100.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Lemaitre Vasculr's operating cash flow?

Lemaitre Vasculr (LMAT) generated $81.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Lemaitre Vasculr's total assets?

Lemaitre Vasculr (LMAT) had $615.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Lemaitre Vasculr's capital expenditures?

Lemaitre Vasculr (LMAT) invested $6.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Lemaitre Vasculr spend on research and development?

Lemaitre Vasculr (LMAT) invested $14.1M in research and development during fiscal year 2025.

Does Lemaitre Vasculr buy back shares?

Yes, Lemaitre Vasculr (LMAT) spent $1.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Lemaitre Vasculr have outstanding?

Lemaitre Vasculr (LMAT) had 23M shares outstanding as of fiscal year 2025.

What is Lemaitre Vasculr's current ratio?

Lemaitre Vasculr (LMAT) had a current ratio of 12.89 as of fiscal year 2025, which is generally considered healthy.

What is Lemaitre Vasculr's debt-to-equity ratio?

Lemaitre Vasculr (LMAT) had a debt-to-equity ratio of 0.56 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Lemaitre Vasculr's return on assets (ROA)?

Lemaitre Vasculr (LMAT) had a return on assets of 9.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Lemaitre Vasculr's Altman Z-Score?

Lemaitre Vasculr (LMAT) has an Altman Z-Score of 8.70, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Lemaitre Vasculr's Piotroski F-Score?

Lemaitre Vasculr (LMAT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Lemaitre Vasculr's earnings high quality?

Lemaitre Vasculr (LMAT) has an earnings quality ratio of 1.41x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Lemaitre Vasculr cover its interest payments?

Lemaitre Vasculr (LMAT) has an interest coverage ratio of 13.1x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Lemaitre Vasculr?

Lemaitre Vasculr (LMAT) scores 79 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.